Shopping Cart (0)
My Account

Your Shopping Cart
Metabomeeting 2014Drug Discovery India 2014Enabling Genomic Technologies and Screening Asia 2014Drug Metabolism & Discovery ADMETIndian Lab Automation20% Discount OfferePoster Award PrizeBlogs

Companion Diagnostics and Personalized Medicine Market Report 2012

Publisher: Select Biosciences
Published: August 2012
Pages: 130


Up-to-Date Market Analyses of the CDx Field

This is the latest and most up-to-date Market Report from Select Biosciences addressing the companion diagnostics (CDx) and personalized medicine marketplace.  Personalized medicine is a broad field with several stakeholders all of which must be aligned in order to capture the immense potential value in targeting therapeutics to the correct patient population—the field of stratified medicine.

Companion Diagnostics has been rapidly expanding over the past 3 years and in this market report we describe the current state of the marketplace from the following perspectives:

  • All the Prognostic and Predictive Biomarkers with Potential Clinical Utility are described—a few have already been developed into CDx and we expect growth in this space
  • Targeted Therapeutics, Associated Biomarkers, Therapeutic Indications, and Testing Mandates are Described
  • Companion Diagnostics Partnerships and Collaborations from 2009 to 2012 are Presented—Provides an Up-to-Date State of the Industry Describing the Disease Areas being Addressed and Types of Biomarkers Being Deployed
  • Quantitative Market Metrics
    • Quantitative Market Forecast: Market Sizing and Growth Rate
    • Revenue Breakout: Rx versus Dx
    • Targeted Rx and CDx Pricing
  • Publication Hotspot Analyses of the Various Cancer Biomarker Classes for Identifying Niches of Market Opportunity in Various Disease Classes

This data-driven characterization of the Companion Diagnostics and Personalized Medicine field is a hands-on document that can be used for competitive benchmarking, business planning, and strategy development—all the data that have been collected in this industry analysis are presented and they form the basis for the conclusions drawn throughout the market report presented in a format enabling “drag-and-drop” into business presentations/business plans—this Market Report is written and delivered to customers in PowerPoint format.

Extensive Market Analyses Presented in this Report

Personalized Medicine and Companion Diagnostics: Market Segmentation and Quantitative Analysis

  • Prognostic Biomarkers in Cancer Listing, Description, and Clinical Significance
  • Predictive Biomarkers in Cancer Listing, Description, and Clinical Significance
  • Summary of Pathways to Regulatory Approval of Companion Diagnostics
  • LDTs under CLIA Certification
  • Outcomes with Drugs in Various Disease Classes
  • Percent of Tumor Classes where Tumors are Associated with Characterized Somatic Mutations
  • Companion Diagnostics and Personalized Medicine: Quantitative Market Metrics
    • How Much Does it Cost to Develop a Companion Diagnostic?
    • Precedent for Premium Pricing in Cancer Targeted Therapeutics
    • Pricing of Selected Personalized Medicine Tests
    • Growth of the Personalized Medicine Marketplace: Market Size/Forecast and Growth Rate

Personalized Medicine Industry Landscape: Selected Indications, Biomarkers and Therapeutics

Market Trends and Evolution of the CDx Marketplace

  • Disparities between Rx and CDx Companies
  • Varying Economic Incentives between Rx and Dx Development
  • Increasing Targeted Rx in the Oncology Space and Effect on CDx Development
  • Current Rx/CDx Co-development Programs in Phase III Trials with Listing of Associated Biomarkers
  • Cancer Classes Addressable by CDx
  • Characterization of Molecular Biomarker Classes: Hotspot Analysis of Publications
    • Cancer Biomarkers
    • Oncogenes
    • Tumor Suppressor Genes
    • Non-coding RNAs
  • Collaborations and Partnering in the CDx Space
    • 2012
    • 2011
    • 2010
    • 2009

Report Table of Contents (TOC) [Click Here to Download PDF File]

For enquiries about this market report, please contact Kathy Gray at

Conference News
Keynote Speakers Confirmed, Carlos Caldas and Mark Caulfield
We are thrilled to announce that Professor Carlos Caldas, Group Leader at the Cancer Research UK Cambridge Institute and Professor Mark Caufield, Chief Scientist of the Genomics England 100,000 project, have both confirmed their keynote presentations at Personalized Medicine in May 2015, Cambridge.

SONY DADC PreConference Workshop, September 17, 2014 from 16:30-18:30
SONY DADC PreConference Workshop, September 17, 2014 from 16:30-18:30
Defining Commercialization Roadmaps for Emerging Technologies into Smart Consumables for in-vitro Diagnostics. Free Admission to this PreConference Workshop.

Submission Deadline Extended to the 15 August 2014
Submission Deadline Extended to the 15 August 2014
Submit your abstract for consideration to present at Lab-on-a-Chip Asia - Microfluidics and Point-of-Care Diagnostics.

Lunchtime Workshop
Lunchtime Workshop
Expanding Reproducibility and Coverage for Biofilm Metabolomics Workshop and Ion Chromatography Coupling to HR/AM Orbitrap Mass Spectrometry for Metabolomic Analysis in Oral Cancer Cells Workshop

Papers presented in Drug Discovery India 2014 conference will be published in CRDD.
Papers presented in Drug Discovery India 2014 conference will be published in CRDD.
The Proceedings of Drug Discovery India 2014 conference will be published in a Special Issue of Current Research in Drug Discovery (CRDD) an online, free access, peer reviewed journal. To make the conference proceedings a timely publication, the authors are requested to submit the manuscripts prior to the start of the conference.

Poster Prizes
Poster Prizes
We are happy to announce that courtesy of the Metabolomics Society we will providing 5 travel awards and a best talk award for students attending Metabomeeting who are members of the Metabolomics Society. There are five travel wards of £350 and 1 prize for the best student talk of £250. To be eligible for these awards all you need be is a student member of the Metabolomics Society. Abstracts and the talk will be judged at the meeting and awards made on the award ceremony on Friday 12th Septembe

Scroll Up
Scroll Down
Keep me updated Select Bio Blog LinkedIn Twitter